Optimization of Fluorescently Labeled Nrf2 Peptide Probes and the Development of a Fluorescence Polarization Assay for the Discovery of Inhibitors of Keap1-Nrf2 Interaction

被引:82
作者
Inoyama, Daigo [1 ]
Chen, Yu [1 ]
Huang, Xinyi [1 ]
Beamer, Lesa J. [2 ]
Kong, Ah-Ng Tony [3 ,4 ]
Hu, Longqin [1 ,4 ]
机构
[1] Rutgers State Univ, Dept Med Chem, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA
[2] Univ Missouri, Dept Biochem, Columbia, MO USA
[3] Rutgers State Univ, Dept Pharmaceut, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA
[4] Canc Inst New Jersey, New Brunswick, NJ USA
基金
美国国家卫生研究院;
关键词
Nrf2; Keap1; ARE; fluorescence polarization; high-throughput screening; oxidative response; OXIDATIVE STRESS; KELCH DOMAIN; CANCER CHEMOPREVENTION; BINDING; PATHWAY; PROTEIN; NEH2; MAF; UBIQUITINATION; IDENTIFICATION;
D O I
10.1177/1087057111430124
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Activation of the antioxidant response element (ARE) upregulates enzymes involved in detoxification of electrophiles and reactive oxygen species. The induction of ARE genes is regulated by the interaction between redox sensor protein Keap1 and the transcription factor Nrf2. Fluorescently labeled Nrf2 peptides containing the ETGE motif were synthesized and optimized as tracers in the development of a fluorescence polarization (FP) assay to identify small-molecule inhibitors of the Keap1-Nrf2 interaction. The tracers were optimized to increase the dynamic range of the assay and their binding affinities to the Keap1 Kelch domain. The binding affinities of Nrf2 peptide inhibitors obtained in our FP assay using FITC-9mer Nrf2 peptide amide as the probe were in good agreement with those obtained previously by a surface plasmon resonance assay. The FP assay exhibits considerable tolerance toward DMSO and produced a Z' factor greater than 0.6 in a 384-well format. Further optimization of the probe led to cyanine-labeled 9mer Nrf2 peptide amide, which can be used along with the FITC-9mer Nrf2 peptide amide in a high-throughput screening assay to discover small-molecule inhibitors of Keap1-Nrf2 interaction.
引用
收藏
页码:435 / 447
页数:13
相关论文
共 50 条
[41]   Discovery of benzo[g]indoles as a novel class of non-covalent Keap1-Nrf2 protein-protein interaction inhibitor [J].
Yasuda, Daisuke ;
Yuasa, Akihiro ;
Obata, Rika ;
Nakajima, Mao ;
Takahashi, Kyoko ;
Ohe, Tomoyuki ;
Ichimura, Yoshinobu ;
Komatsu, Masaaki ;
Yamamoto, Masayuki ;
Imamura, Riyo ;
Kojima, Hirotatsu ;
Okabe, Takayoshi ;
Nagano, Tetsuo ;
Mashino, Tadahiko .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (22) :5006-5009
[42]   Activation of NRF2 Signaling in HEK293 Cells by a First-in-Class Direct KEAP1-NRF2 Inhibitor [J].
Wen, Xia ;
Thorne, Gabriell ;
Hu, Longqin ;
Joy, Melanie S. ;
Aleksunes, Lauren M. .
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2015, 29 (06) :261-266
[43]   Recent progress and applications of small molecule inhibitors of Keap1-Nrf2 axis for neurodegenerative diseases [J].
Wang, Jing ;
Cao, Yu ;
Lu, Yang ;
Zhu, Huajian ;
Zhang, Jiankang ;
Che, Jinxin ;
Zhuang, Rangxiao ;
Shao, Jiaan .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 264
[44]   Design, synthesis and evaluation of novel small molecules acting as Keap1-Nrf2 protein-protein interaction inhibitors [J].
Sun, Yunfeng ;
Zheng, Lulu ;
Yang, Bo ;
Ge, Shuyu ;
Li, Qiang ;
Zhang, Mingwan ;
Shen, Shenghui ;
Ying, Yin .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2022, 37 (01) :2575-2588
[45]   Discovery of disubstituted xylylene derivatives as small molecule direct inhibitors of Keap1-Nrf2 protein-protein interaction [J].
Abed, Dhulfiqar Ali ;
Lee, Sumi ;
Hu, Longqin .
BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (06)
[46]   New insights into the mechanism of Keap1-Nrf2 interaction based on cancer-associated mutations [J].
Cheng, Liangkai ;
Wang, Huihui ;
Li, Shehan ;
Liu, Zhongqiu ;
Wang, Caiyan .
LIFE SCIENCES, 2021, 282
[47]   Pharmacological characterization of a novel peptide inhibitor of the Keap1-Nrf2 protein-protein interaction [J].
Aparici, Monica ;
Bravo, Monica ;
Calama, Elena ;
Garcia-Gonzalez, Vicente ;
Domenech, Teresa ;
Cordoba, Monica ;
Roger, Ines ;
Cortijo, Julio ;
Gongora-Benitez, Miriam ;
Paradis-Bas, Marta ;
Collins, Barry ;
Davis, Andrew M. ;
Albericio, Fernando ;
Puig, Carlos .
BIOCHEMICAL PHARMACOLOGY, 2022, 204
[48]   Anti-inflammatory Effect of a Cell-Penetrating Peptide Targeting the Nrf2/Keap1 Interaction [J].
Steel, Richard ;
Cowan, Jonathan ;
Payerne, Estelle ;
O'Connell, Maria A. ;
Searcey, Mark .
ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (05) :407-410
[49]   Impaired antioxidant KEAP1-NRF2 system in amyotrophic lateral sclerosis: NRF2 activation as a potential therapeutic strategy [J].
Silvia Bono ;
Marco Feligioni ;
Massimo Corbo .
Molecular Neurodegeneration, 16
[50]   Discovery of a small-molecule inhibitor and cellular probe of Keap1-Nrf2 protein-protein interaction [J].
Hu, Longqin ;
Magesh, Sadagopan ;
Chen, Lin ;
Wang, Lili ;
Lewis, Timothy A. ;
Chen, Yu ;
Khodier, Carol ;
Inoyama, Daigo ;
Beamer, Lesa J. ;
Emge, Thomas J. ;
Shen, Jian ;
Kerrigan, John E. ;
Ah-Ng Tony Kong ;
Dandapani, Sivaraman ;
Palmer, Michelle ;
Schreiber, Stuart L. ;
Munoz, Benito .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (10) :3039-3043